All Articles

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

Eikon Therapeutics adds a consumer goods giant to its board, a move signaling a strategic pivot from pure science to global commercialization.

MAX Power is shedding its lithium asset to go all-in on natural hydrogen. A look at the strategic choice that splits the energy transition in two.

As National Outlet Shopping Day returns, it's more than a sale. It's Simon's blueprint for the future of retail and a key test of consumer spending.

As travel habits shift, new business models and government incentives are making Canada's waterways more accessible than ever, fueling a multi-billion dollar industry.

A new report reveals a dangerous disconnect: while AI accelerates coding, 95% of CISOs are pressured to ignore the security flaws it creates.

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

With 80% of trials delayed, the life sciences industry is gathering to tackle its patient enrollment crisis. Can new partnerships and AI finally move the needle?

Johnson & Johnson's acquisition of Firefly Bio for $1 billion signals a major push into degrader antibody conjugates, a new frontier for treating KRAS cancers.

Luxardo's new Decaf Espresso Liqueur isn't just a new bottle. It's a strategic move to capture the mindful drinking trend and dominate the espresso martini scene.

The AvalonBay-Equity merger just named its leaders. It's not just a new C-suite; it's a blueprint for a tech-driven, $69B titan set on dominating the rental market.

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

A new campaign frames fusion energy as a U.S.-China security race. But beyond the hype, what is the reality of the global push for limitless power?

K-beauty leader Rael disrupts the U.S. market with advanced hydrogel masks and the first Korean-made tampon, pioneering a new era of 'K-Wellness'.

The promotion of Tony Pallas to CTO is no mere shuffle. It's a calculated move to arm thousands of franchisees with AI, signaling a new front in the war for hospitality tech dominance.

Altera's Agilex 9 FPGA packs RF, compute, and memory into one chip, promising a leap in performance for defense, aerospace, and next-gen communications.